BSE filing, NSE: TOHELPH. Summary written from the filing by ALFA Finder's alert engine.
JOJO Ltd: key numbers
- Share price
- ₹114.60
- Market cap
- ₹1,581 Cr
- Revenue (annual)
- ₹24.01 Cr
- Net profit (annual)
- ₹5.62 Cr
- P/E (TTM)
- 225.1×Sector 27.9×
- Promoter holding
- 63.17%-4.62% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JOJO Ltd
All →JOJO Stock Split
JOJO Ltd's board approved sub-dividing its equity shares from Rs.5 to Rs.1 face value, a 1-into-5 split, subject to shareholder approval. A postal ballot has been approved to seek that approval.
- Execution
- Within 2 months of board approval, subject to approvals
JOJO Merger & Restructuring
JoJo Ltd's board approved incorporating 'Jojo Holdings Ltd,' a private company in Dubai's DIFC. This revised Reg 30 filing corrects the earlier announcement's meeting-timing details.
JOJO Board Meeting Date
JOJO Ltd scheduled a 4 November 2026 board meeting to consider unaudited half-year results. The filing is a future meeting notice, with no results yet approved.
JOJO Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.
JOJO Stock Split
JoJo Limited announced a board meeting on October 26, 2026, to consider a stock split, reducing the face value of shares from Rs. 5 to Rs. 1.
JOJO Merger & Restructuring
JoJo Limited's board approved incorporating a new subsidiary in the Dubai International Financial Centre (DIFC). Further details regarding the entity will be disclosed in due course.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.